Real-world evidence analytics is emerging as a strategically critical capability within China's life science sector as the National Medical Products Administration progressively implements regulatory frameworks that recognize real-world data sources including electronic health records, insurance claims databases, patient registries, and pragmatic clinical trial designs as valid evidence inputs...

Commercial analytics has emerged as a critical competitive differentiator in the pharmaceutical industry, with companies that deploy sophisticated prescriber behavior analytics, patient journey mapping, market access optimization modeling, and sales force effectiveness measurement gaining meaningful commercial performance advantages over competitors relying on conventional field force...